Several pro-inflammatory cytokines and their associated pathways, which are known to promote cancer cell proliferation in many cases [30], were implicated in typical responders throughout this study, including IL6, CCL20, CXCL8, TNF signaling, and IL-17 signaling. This evidence concerns the gene IL6 and cancer.